Cite
HARVARD Citation
Costa, M. et al. (n.d.). Clinical benefit and tolerability of CDK4/6 inhibitors in the treatment of breast cancer advanced in the geriatric population – real life data from a Hospital Center. European journal of cancer. pp. S63-. [Online].